Clinical Trial

Continuous Glucose Monitoring: A Pilot Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate connectivity of the FDA approved DexCom G7® continuous glucose monitor in the operating room. Continuous glucose monitors are applied to the skin and a thin sampling filament is inserted into the skin and measures blood sugar in the interstitial fluid. The DexCom G7® is used regularly outside of the operating room to monitor blood sugar, however the use of the device in the operating room environment has been limited by connectivity issues. This study will assess device connectivity at different monitoring sites.
Protocol Amendment History 2 changes
notable Enrollment increased: 40 -> 45 participants 2026-08-14
notable Primary completion moved earlier: 2026-10 -> 2025-08-01 2026-08-14
Trial Details
NCT Number NCT06614127
Lead Sponsor Loma Linda University
Conditions Anesthesia
Enrollment 45 participants
Start Date 2024-10-24
Primary Completion 2025-08-01 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13